By Matt Terry, March 17, 2017
Two McMaster students will spend the summer learning about the relationship between culture and identity in five different countries around the world.
Medical student Kira Gossack-Keenan will travel to India, Cambodia and Vietnam to find out how the region's inhabitants relate to and interact with those with physical disabilities. She'll also study the relationship between disability and art, while producing some artistic works of her own along the way.
"We're not perfect in Canada, but we try to incorporate accommodation into many of the things we do," says Gossack-Keenan. "In many countries, access to the physical environment continues to be less accessible to those with disabilities, and I'd like to explore this issue."
Dr. William (Bill) Bensen, a nationally recognized rheumatologist who was a McMaster alumnus, faculty member and donor, died March 15. He was 67.
Bill Bensen came from a family with a long history in Hamilton and particularly at McMaster, with his grandfather, father and son, Rob all graduating with degrees from the University.
He was in the second graduating class of what is now known as the Michael G. DeGroote School of Medicine, in 1973. He became a part-time faculty member with the Department of Medicine in 1978 and had held the title of clinical professor since 2007.
An international research team with prominent Canadian leadership has found that the blood thinner rivaroxaban is as safe as aspirin, and more effective at preventing recurrence of life-threatening blood clots in the legs and lungs, according to a study published in the New England Journal of Medicine.
At least one out of 1,000 Canadians will experience one of these blood clots every year, a condition called venous thromboembolism. The clots can be deadly if they travel to the lungs (pulmonary embolism), and are the third most common cardiovascular cause of death after heart attack and stroke.
Venous thromboembolism is a chronic disease, with risks of additional blood clots over a patient's lifetime. However, many physicians and patients are deciding against long-term treatment with blood thinners because of concern about the risk of bleeding. Some are choosing aspirin instead because they consider it to be safer.